|
1
|
Fisichella R and Llleshi A: Respiratory
cancers and pollution. Eur Rev Med Pharmacol Sci. 19:3327–3328.
2015.PubMed/NCBI
|
|
2
|
Cahill G, Tran L, Baker RA, Brown A, Huang
YC and Ou CW: Principles of radiation oncology. Asian Pac J Surg
Oncol. 1:27–38. 2015.
|
|
3
|
Liu CX, Wang H, Qian XM, Lu FX, Zhuang SF,
Yang MX, Wang FL and Wang YT: The effect of three-dimensional
conformal radiotherapy on locally recurrent nasopharyngeal
carcinoma and on the expression of succinate dehydrogenase B. Eur
Rev Med Pharmacol Sci. 20:4852–4857. 2016.PubMed/NCBI
|
|
4
|
Chen JL, Huang YS, Kuo SH, Hong RL, Ko JY,
Lou PJ and Wang CW: Intensity-modulated radiation therapy achieves
better local control compared to three-dimensional conformal
radiation therapy for T4- stage nasopharyngeal carcinoma.
Oncotarget. 18:1123–1124. 2016.
|
|
5
|
Wang J, Zhou Z, Liang J, Feng Q, Xiao Z,
Hui Z, Wang X, Lv J, Chen D, Zhang H, et al: Intensity-modulated
radiation therapy may improve local-regional tumor control for
locally advanced non-small cell lung cancer compared with
three-dimensional conformal radiation therapy. Oncologist.
21:1530–1537. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang F, Liu Q and Hu CM: Epstein-Barr
virus-encoded LMP1 increases miR-155 expression, which promotes
radioresistance of nasopharyngeal carcinoma via suppressing UBQLN1.
Eur Rev Med Pharmacol Sci. 19:4507–4515. 2015.PubMed/NCBI
|
|
7
|
Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu
LZ, Sun Y, Lin AH, Liu MZ and Ma J: How does intensity-modulated
radiotherapy versus conventional two-dimensional radiotherapy
influence the treatment results in nasopharyngeal carcinoma
patients? Int J Radiat Oncol Biol Phys. 80:661–668. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Petsuksiri J, Sermsree A, Thephamongkhol
K, Keskool P, Thongyai K, Chansilpa Y and Pattaranutaporn P:
Sensorineural hearing loss after concurrent chemoradiotherapy in
nasopharyngeal cancer patients. Radiat Oncol. 6:192011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fang FM, Chien CY, Tsai WL, Chen HC, Hsu
HC, Lui CC, Huang TL and Huang HY: Quality of life and survival
outcome for patients with nasopharyngeal carcinoma receiving
three-dimensional conformal radiotherapy vs. intensity-modulated
radiotherapy-a longitudinal study. Int J Radiat Oncol Biol Phys.
72:356–364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang R, Wu F, Lu H, Wei B, Feng G, Li G,
Liu M, Yan H, Zhu J, Zhang Y, et al: Definitive intensity-modulated
radiation therapy for nasopharyngeal carcinoma: Long-term outcome
of a multicenter prospective study. J Cancer Res Clin Oncol.
139:139–145. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Han L, Lin SJ, Pan JJ, Chen CB, Zhang Y,
Zhang XC, Liao XY and Chen QS: Prognostic factors of 305
nasopharyngeal carcinoma patients treated with intensity-modulated
radiotherapy. Chin J Cancer. 29:145–150. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Budach W, Hehr T, Budach V, Belka C and
Dietz K: A meta-analysis of hyperfractionated and accelerated
radiotherapy and combined chemotherapy and radiotherapy regimens in
unresected locally advanced squamous cell carcinoma of the head and
neck. BMC Cancer. 6:282006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tao CJ, Liu X, Tang LL, Mao YP, Chen L, Li
WF, Yu XL, Liu LZ, Zhang R, Lin AH, et al: Long-term outcome and
late toxicities of simultaneous integrated boost-intensity
modulated radiotherapy in pediatric and adolescent nasopharyngeal
carcinoma. Chin J Cancer. 32:525–532. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su SF, Han F, Zhao C, Chen CY, Xiao WW, Li
JX and Lu TX: Long-term outcomes of early-stage nasopharyngeal
carcinoma patients treated with intensity-modulated radiotherapy
alone. Int J Radiat Oncol Biol Phys. 82:327–333. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haberer-Guillerm S, Touboul E and Huguet
F: Intensity modulated radiation therapy in nasopharyngeal
carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 132:147–151.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qu S, Liang ZG and Zhu XD: Advances and
challenges in intensity-modulated radiotherapy for nasopharyngeal
carcinoma. Asian Pac J Cancer Prev. 16:1687–1692. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang H, Hu W, Wang W, Chen P, Ding W and
Luo W: Replanning during intensity modulated radiation therapy
improved quality of life in patients with nasopharyngeal carcinoma.
Int J Radiat Oncol Biol Phys. 85:e47–e54. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang W, Yang H, Hu W, Shan G, Ding W, Yu
C, Wang B, Wang X and Xu Q: Clinical study of the necessity of
replanning before the 25th fraction during the course of
intensity-modulated radiotherapy for patients with nasopharyngeal
carcinoma. Int J Radiat Oncol Biol Phys. 77:617–621. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roeder F, Zwicker F, Saleh-Ebrahimi L,
Timke C, Thieke C, Bischof M, Debus J and Huber PE: Intensity
modulated or fractionated stereotactic reirradiation in patients
with recurrent nasopharyngeal cancer. Radiat Oncol. 6:222011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Popovtzer A, Gluck I, Chepeha DB, Teknos
TN, Moyer JS, Prince ME, Bradford CR and Eisbruch A: The pattern of
failure after reirradiation of recurrent squamous cell head and
neck cancer: Implications for defining the targets. Int J Radiat
Oncol Biol Phys. 74:1342–1347. 2009. View Article : Google Scholar : PubMed/NCBI
|
